Boston, April 18: Diabetes and epidemic can be considered as synonyms in the present context. A report from WHO has informed that an estimated 422 million adults were living with diabetes in 2014. The latest statistics from WHO states that 64.5 million people suffer from Diabetes in India. As a savior of the human race, the Vaccine against Diabetes has been officially announced.
At the 75th Scientific Sessions of the American Diabetes Association, it was announced that the Food and Drugs Administration will test the vaccine on 150 people who are in an advanced stage of type one diabetes.
An individual who suffers from type-1 diabetes their body cannot produce enough insulin. The cells that create insulin get destroyed. Added to that the body produces T cells that also harms the pancreatic islets. The vaccine eliminates harmful T cells.
Diabetic patients were injected the vaccine and the levels of the compound called necrosis factor increased. The T cells which obstruct the production of insulin can be ruined by increased level of TNF.
Dr. Denise Faustman, director of the Massachusetts General Healthcare facility Immunobiology Laboratory in Boston, is extremely excited about the outcomes the BCG vaccine has been revealing.“In the phase I (preliminary) trial we demonstrated a statistically considerable action to BCG, but our goal in (this trial) is to develop an enduring restorative action. We will be working once again with people who have had type 1 diabetes for several years. This is not a prevention trial; rather, we are attempting to create a routine that will treat even advanced illness” discussed Dr. Denise.